MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education
MATAspire
1 other identifier
interventional
1,000
0 countries
N/A
Brief Summary
The MATAspire intervention is a web-app designed to promote substance misuse prevention education and bolster protective coping skills whereby students complete six weekly interactive modules using a smart device or computer. Each module is approximately 15-20 minutes long and focuses on select substances and coping strategies: (i) adaptive coping strategies, (ii) alcohol, (iii) cannabis, (iv) nicotine, (v) prescription drugs and opioids, (vi) final module. The modules are based on key theoretical constructs, behavior change strategies, and practical module components: attitudes (knowledge), perceived susceptibility (risk perceptions), and subjective norms (normative re-education). The intervention will be evaluated via a time series design using a sample of (\~1000 students) randomly assigned to either the intervention or the control conditions at a public institution in Southern California.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2024
CompletedFirst Posted
Study publicly available on registry
August 14, 2024
CompletedStudy Start
First participant enrolled
August 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
August 14, 2024
August 1, 2024
3.7 years
August 8, 2024
August 12, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Change from baseline alcohol use behavior at 3 months
Measured as the number of days drinking alcohol in past 30-days
Baseline and 90-days following intervention completion
Change from baseline binge drinking at 3 months
Measured as the number of days consumed five or more alcoholic beverages at the same time for males; four or more for females in past 30-days
Baseline and 90-days following intervention completion
Change from baseline cannabis use at 3 months
Measured as the number of days smoking, vaping, dabbing, oral (edibles/gummies/drinks), sprays, tinctures, and topically in past 30-days
Baseline and 90-days following intervention completion
Change from baseline nicotine use at 3 months
Measured as the number of days using menthol cigarettes, regular cigarettes, loose tobacco rolled into cigarettes or cigars, pipe tobacco, snuff, chewing tobacco, dipping tobacco, snus, and others in past 30-days
Baseline and 90-days following intervention completion
Change from baseline electronic vape use products at 3 months
Measured as the number of days using vaporizers, vape pens, hookah pens, electronic cigarettes, e-pens, or electronic nicotine delivery systems in past 30-days
Baseline and 90-days following intervention
Change from baseline non-prescribed prescription drug use behavior at 3 months
Measured as the number of days used stimulants, sedatives, benzodiazepines, and prescription opioids in past 30-days
Baseline and 90-days following intervention completion
Change from baseline coping skills at 3 months
Measured as the degree of effective and ineffective ways to cope with a stressful life event in ...
Baseline and 90-days following intervention completion
Secondary Outcomes (4)
Change from baseline alcohol use related outcomes at 3 months
Baseline and 90-days following intervention completion
Change from baseline nicotine use related outcomes at 3 months
Baseline and 90-days following intervention completion
Change from baseline cannabis use related outcomes at 3 months
Baseline and 90-days following intervention completion
Change from baseline non-prescribed prescription drug use related outcomes at 3 months
Baseline and 90-days following completion of intervention
Other Outcomes (11)
Change from baseline risk perceptions at 3 months
Baseline and 90-days following intervention completion
Change from baseline subjective norms at 3 months
Baseline and 90-days following intervention completion
Change from baseline attitudes at 3 months
Baseline and 90-days following intervention completion
- +8 more other outcomes
Study Arms (2)
Prevention group
EXPERIMENTALWeb-app with 6 weekly coping \& substance modules
Control Group
NO INTERVENTIONNo access to web-app
Interventions
Substance misuse prevention education and adaptive coping skills
Eligibility Criteria
You may qualify if:
- Current Cal State Northridge (CSUN) matriculated students with active CSUN email
- Age 18 and older
You may not qualify if:
- Not currently a CSUN student
- CSUN students under the age of 18 years
- Have previously participated in this study
- Identified as having an alcohol or substance use disorder (AUD or SUD) as determined by the brief Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 screener
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Department Chair, Professor
Study Record Dates
First Submitted
August 8, 2024
First Posted
August 14, 2024
Study Start
August 24, 2024
Primary Completion (Estimated)
May 15, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
August 14, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share